Alternatives to Oxford Science Enterprises

The University of Edinburgh's venture investment arm supporting early-stage spin-outs and student startups.

An accelerator program for life science startups.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Unleashing the power of genomics at scale for biological advances and human health.

A venture capital firm focused on deeptech innovation.

Global venture capital firm backing ambitious entrepreneurs from seed to IPO across technology and life sciences.

AI-driven digital twin of embryo development for cell-based therapies.

Dot Compliance provides an AI-powered eQMS for life sciences companies to accelerate product delivery and reduce costs.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Advanced infectious disease diagnostics

Upcycles food waste into high-value lactic acid using climate-transformative technology.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Accelerating the development of breakthrough new medicines and medical technologies.

AI-powered blood test for early cancer detection and subtyping.